Log inSign up
Anand V Kulkarni
4,708 posts
user avatar
Anand V Kulkarni
@AnandVKulkarni2
Hepatologist @ Asian Institute of Gastroenterology. Director-Critical Care Hep. Interests in ALD, ACLF & HCC
Hyderabad, India
Joined April 2016
2,976
Following
4,082
Followers

New to X?

Sign up now to get your own personalized timeline!

Create account

By signing up, you agree to the Terms of Service and Privacy Policy, including Cookie Use.

Terms·Privacy·Cookies·Accessibility·Ads Info·© 2026 X Corp.
Don't miss what's happening
People on X are the first to know.
Log inSign up
  • Pinned
    user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Apr 23
    Thank you @APASLnews ⁦@APASL2026⁩ for the recognition. This comes with a responsibility to work more for our patients and advance science in right direction. #Humbled Thanks to my family, friends and mentors !!
    7.7K
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Jun 7, 2022
    How to diagnose and prevent infection in cirrhosis! now @SeminLiverDis thieme-connect.com/products/ejour… @DrDNReddy Dr. PN Rao, Dr. Raj Reddy, @rabataller @DrPMonga @DrLoomba @JasmohanBajaj @salvatore_piano @ajay_duseja @RajivJalan1 @ID_fellows @CCO_InfDis @INASL_Liver #livertwitter
    Figure 1: Mechanism of sepsis in cirrhosis.
    Strategies to prevent infection/improve outcomes
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Oct 17, 2020
    Terlipressin in 2020. An indepth review published in @LiverInt by @juanpabloarab @younghepat @DrMithunSharma @DougSimonetto #livertwitter @AASLDtweets @EASLedu @INASL_Liver @AmerGastroAssn @AST_LICOP @AST_info onlinelibrary.wiley.com/doi/abs/10.111…
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Oct 27, 2021
    Honoured to receive early career investigator award from @AASLDFoundation for our abstract to be presented @AASLDtweets #TLMdX2021 #LiverMtg21 Thanks a lot for motivating me to do more work on liver diseases/LT and contribute to patient care.🙏 #livertwitter
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Jan 19, 2022
    Primary Norfloxacin Prophylaxis for APASL-Defined ACLF is now online @AmJGastro @AmCollegeGastro @JasmohanBajaj @MLongMD @APASL_AARC @APASLnews @DrMithunSharma @docMPK @karanbjmc93 #LiverTwitter journals.lww.com/ajg/Abstract/9…
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Mar 28, 2024
    There are various definitions of ACLF but a clear & standardised definition is lacking. Here we propose steps for harmonisation. @EASLnews @EASLedu @AASLDtweets @BavenoCoop @APASL_AARC @APASLnews @ProfPaoloAngeli @drshivsarin @JHepatology #livertwitter
    Acute-on-chronic liver failure – steps towards harmonization of the definition!
    From journal-of-hepatology.eu
    13K
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Nov 13, 2023
    Diwali with friends and Giants of hepatology! ⁩ ⁦@ajay_duseja⁩ ⁦⁦@JasmohanBajaj⁩ ⁦@ebtapper⁩ ⁦@RoyAHep⁩ @drmithunsharma ⁦@manasa_alla⁩ ⁦@drnipunverma⁩ Prof. Reddy , Prof. Sarin, Prof. Kamath, Dr . Ashok, and Dr Ameet. ⁦#TLM23
    4.1K
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Aug 2, 2022
    10 posters and one oral abstract from @AIGHospitals for #TLM2022 @AASLDtweets @AASLDPresident @DrMithunSharma #livertwitter thanks to hard working fellows - Dr @moiz_vora and our data coordinators Drs. Baqar and Sameer
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Oct 22, 2023
    We made a checklist for terli use. May be useful for all physicians ! @DeepikaDevuniMD @JuanAbraldes @acv69cardenas @Htevethia @_LTSI_ @sonalasthana @giri_gutnliver @ebtapper @AtoosaRabiee @LizzieAbyMD @salvatore_piano @ICA_Global_AKI #liverx #livertwitter
    user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Oct 21, 2023
    Terli in HRS AKI- Predictors? Impact on LT ? Can read 👇🏼! Terlipressin in the management of adults with Hrs ⁦@LiverFellow⁩ ⁦@docMPK⁩ ⁦@RoyAHep⁩ ⁦@juanpabloarab⁩ #liverx #livertwitter tandfonline.com/doi/full/10.10…
    13K
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Jul 1, 2022
    In this article,we discuss "The challenges of ascites management: An Indian perspective" aasldpubs.onlinelibrary.wiley.com/doi/full/10.10… @NancyReau @CLD_Learning @docMPK @salvatore_piano @doc_arka @Sanchit30497977 @AtoosaRabiee @ajay_duseja @gvraoaig @AASLDtweets @INASL_Liver #livertwitter #GITwitter
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Nov 17, 2024
    An absolute honour to speak on LDLT in ACLF @AASLDtweets #TLM24 @INASL_Liver @_LTSI_ @sonalasthana @pummy92 @CLindenmeyerMD @dean_karvellas @mcconnell_md @MaiwallRakhi
    user avatar
    Nikki Duong, M.D.
    @doctornikkid
    Nov 16, 2024
    LDLT in #ACLF by @AnandVKulkarni2 ❇️70-90% survival with LDLT ⚠️Ethical challenges ⬆️infections post LT, donor complications ❇️Consider HBcAb donor organs ⏰ is key!
    5.7K
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Jun 24, 2022
    An honour to meet the famous tweetorial specialist ⁦@ebtapper⁩ @ #ILC2022 #livertwitter
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Oct 22, 2023
    Wow!! Thank you @AmCollegeGastro @JasmohanBajaj @MLongMD @AmJGastro for the recognition and wonderful gesture !! 🙏🏻
    user avatar
    AJG - The American Journal of Gastroenterology
    @AmJGastro
    Oct 22, 2023
    ACG thanks the 2023 Top Reviewers of @AmJGastro for their exceptional service! Reviewers play a critical role in publishing high-quality clinical research. Want to become a peer reviewer for ACG's journals? Find out more ➡️ gi.org/journals_regis… @MLongMD @JasmohanBajaj
    7K
  • user avatar
    Anand V Kulkarni
    @AnandVKulkarni2
    Jun 25, 2022
    Blessed to spend some time wid ⁦the GI Ca & Microbiome stalwart, Prof.⁦@emadelomar⁩ Such a humble person filled with warmth..his story of ⁦@MRC_microbiome⁩.. Inspirational!! Research needs dedication & patience. Thank you sir for the time, guidance & Thai food 🙏🏻